Antibody Spike Months After Ebola Infection Surprisingly Common
A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.
Antibody Spike Months After Ebola Infection Surprisingly Common
Antibody Spike Months After Ebola Infection Surprisingly Common
A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.
A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.
New data suggest that the company’s approved COVID-19 vaccine protects against different virus variants, but could be less effective against the one that originated in South Africa.
Knocking out the receptor for a lipid that causes inflammation rejuvenates macrophage metabolism and restores cognitive function in an Alzheimer’s disease model.
The Scientist Creative Services Team | Jan 20, 2021
Discover how scientists use multi-omic approaches to identify functional changes that lead to cancer cell drug resistance and devise new treatment strategies.
A large study of UK healthcare workers finds that immunity after coronavirus infection lasts for months, but those with antibodies may still be able to carry and spread the virus upon reexposure.
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.